Trade Moderna Inc ^MRNA

Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? - December 23, 2024 - Zacks.com

Moderna (NASDAQ:MRNA) vs. Adaptive Biotechnologies (NASDAQ:ADPT) Critical Survey

Personalis shares target increased, buy rating on Merck investment By Investing.com

Moderna, Inc. (MRNA) Faces Criticism from Cramer Amid High R&D Spending and Revenue Struggles

Merck Buys $50 Million of Personalis Stock | Morningstar

Personalis secures investment from Merck, extends Moderna deal By Investing.com

Personalis, Inc. Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna By Investing.com

Moderna (NASDAQ:MRNA) Lowered to “Hold” Rating by Argus

Stifel Financial Corp Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Argus Downgrades Moderna (NASDAQ:MRNA) to Hold | MarketBeat

Hedge Funds Think That Moderna, Inc. (MRNA) Will Bounce Back Soon

Novavax is as protective as other Covid vaccines, but has fewer side effects | Vox

Argus downgrades Moderna to hold on weak near-term outlook By Investing.com

Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of “Hold” from Brokerages

Moderna shares downgraded to hold from buy by Argus on revenue decline By Investing.com

3-Stock Lunch: Palantir, MicroStrategy and Moderna

Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential By Investing.com

Is Moderna Stock Underperforming the Dow?

Quantinno Capital Management LP Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)

MicroStrategy, Palantir added to Nasdaq 100, with Moderna facing an exit | The Star

Generation Bio's SWOT analysis: innovative dna tech stock faces clinical hurdles By Investing.com

Toronto Dominion Bank Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Nasdaq Inc (NDAQ) Announces Annual Reconstitution of Nasdaq-100 Index

Saylor’s MicroStrategy Scores Again With Nasdaq 100 Addition

Moderna, Inc. (NASDAQ:MRNA) Holdings Increased by Inspire Trust Co. N.A.

Public Employees Retirement System of Ohio Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Geode Capital Management LLC

Moderna, Inc. (NASDAQ:MRNA) Given Consensus Rating of "Hold" by Analysts

Moderna's SWOT analysis: stock faces transition as covid vaccine demand wanes By Investing.com

Your Guide to COVID Vaccines for 2024-2025 | MDedge

Moderna Stays Upbeat As Anti-Vaxxers Prepare To Rule In D.C. 12/12/2024

Chelsea Counsel Co. Sells 635 Shares of Moderna, Inc. (NASDAQ:MRNA)

Cancer Vaccines Market worth $20.47 billion in 2032

Moderna, Inc. (NASDAQ:MRNA) Insider Shannon Thyme Klinger Sells 529 Shares

National Bank of Canada FI Acquires 90,739 Shares of Moderna, Inc. (NASDAQ:MRNA)

Bank of America Reaffirms “Underperform” Rating for Moderna (NASDAQ:MRNA)

Pfizer stock outlook dims as 2025 EPS guidance reflects normalization of COVID business By Investing.com

Carisma Therapeutics cut to In Line, stock target slashed on tempered outlook By Investing.com

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates - December 11, 2024 - Zacks.com

Moderna (NASDAQ:MRNA) Shares Down 5.8% – Here’s What Happened

Moderna's (MRNA) Underperform Rating Reiterated at Bank of America

Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2bn Morrison-era deal

Moderna officially opens new vaccine manufacturing facility in Australia

BTIG cuts Carisma Therapeutics to Neutral from Buy By Investing.com

Carisma Therapeutics shifts focus, cuts workforce by 34% By Investing.com

Carisma Therapeutics plans reduction in the workforce by 34% By Investing.com

XTX Topco Ltd Buys 25,400 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by Wellington Management Group LLP

Two Sigma Advisers LP Acquires Shares of 356,500 Moderna, Inc. (NASDAQ:MRNA)

State Street Corp Buys 1,823,276 Shares of Moderna, Inc. (NASDAQ:MRNA)

Chevy Chase Trust Holdings LLC Sells 1,028 Shares of Moderna, Inc. (NASDAQ:MRNA)

Rockefeller Capital Management L.P. Lowers Stake in Moderna, Inc. (NASDAQ:MRNA)

Moderna chief legal officer sells $4,849 in stock By Investing.com

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Lowers Position in Moderna, Inc. (NASDAQ:MRNA)

Arbutus Biopharma's SWOT analysis: focus on CHB treatment drives stock outlook By Investing.com

Moderna president Stephen Hoge sells shares worth $13,595 By Investing.com

Motley Fool Wealth Management LLC Decreases Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn | World News - Business Standard

DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information | Morningstar

Moderna shares could slump over 30% on negative CMV reading: Leerink By Investing.com

Moderna shares face doubts as Leerink questions odds of success in Phase 3 CMV study By Investing.com

Moderna president Stephen Hoge sells shares worth $12,451 By Investing.com

Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?

Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges

Moderna CFO James Mock sells shares worth $60,760 By Investing.com

Arizona PSPRS Trust Purchases Shares of 25,100 Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank

Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Bellevue Group AG

MetLife Investment Management LLC Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (MRNA): A Bull Case Theory

Moderna, Inc. (NASDAQ:MRNA) Holdings Reduced by Northwest & Ethical Investments L.P.

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Bank of Montreal Can

Fmr LLC Has $1.16 Billion Holdings in Moderna, Inc. (NASDAQ:MRNA)

Natixis Advisors LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)

Why Is Moderna, Inc. (MRNA) Among the Worst Performing Healthcare Stocks in 2024?

RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA) | Markets Insider

Moderna (NASDAQ:MRNA) Price Target Cut to $45.00 by Analysts at JPMorgan Chase & Co.

Fall Vaccine Updates From the Advisory Committee on Immunization Practices: New Recommendations | MDedge

JPMorgan Chase & Co. Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price

CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, In

Moderna to Present at Upcoming Conferences in December 2024 | Morningstar

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Citigroup Inc.

Unexpected dovish tone from RBNZ drops New Zealand dollar

Sterling steady near one-month high in wake of UK election

BP shares drop over 4% on Q2 lower profit warning

BP dips, Powell Congress speech ahead, records for Tokyo, NY